1. Home
  2. BTMD vs SACH Comparison

BTMD vs SACH Comparison

Compare BTMD & SACH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Biote Corp.

BTMD

Biote Corp.

HOLD

Current Price

$1.10

Market Cap

39.0M

Sector

Health Care

ML Signal

HOLD

Logo Sachem Capital Corp.

SACH

Sachem Capital Corp.

HOLD

Current Price

$0.88

Market Cap

38.4M

Sector

Real Estate

ML Signal

HOLD

Company Overview

Basic Information
Metric
BTMD
SACH
Founded
2012
2010
Country
United States
United States
Employees
N/A
N/A
Industry
Medicinal Chemicals and Botanical Products
Real Estate Investment Trusts
Sector
Health Care
Real Estate
Exchange
Nasdaq
Nasdaq
Market Cap
39.0M
38.4M
IPO Year
2021
2016

Fundamental Metrics

Financial Performance
Metric
BTMD
SACH
Price
$1.10
$0.88
Analyst Decision
Strong Buy
Analyst Count
5
0
Target Price
★ $2.61
N/A
AVG Volume (30 Days)
123.7K
★ 169.7K
Earning Date
11-04-2026
11-04-2026
Dividend Yield
N/A
★ 22.73%
EPS Growth
★ 722.22
104.30
EPS
★ N/A
N/A
Revenue
★ $192,219,000.00
$57,500,000.00
Revenue This Year
N/A
$94.91
Revenue Next Year
$5.45
N/A
P/E Ratio
★ N/A
N/A
Revenue Growth
★ N/A
N/A
52 Week Low
$1.10
$0.76
52 Week High
$3.26
$1.45

Technical Indicators

Market Signals
Indicator
BTMD
SACH
Relative Strength Index (RSI) 27.63 43.17
Support Level N/A $0.77
Resistance Level $1.68 $0.99
Average True Range (ATR) 0.07 0.03
MACD -0.00 -0.01
Stochastic Oscillator 1.52 12.40

Price Performance

Historical Comparison
BTMD
SACH

About BTMD Biote Corp.

Biote Corp operates a growth practice-building business within the hormone optimization space. It provides the necessary components to enable Biote-certified practitioners to establish, build, and successfully implement a program designed to optimize hormone levels using personalized solutions for their patient populations. The company provides support to medical practitioners through training, practice development, and operational services to establish and manage hormone therapy centers. Its activities include educating practitioners on identifying and treating hormone-related conditions. The company generates revenues by charging the Biote-partnered clinics fees associated with the Biote Method and from the sale of Biote-branded dietary supplements.

About SACH Sachem Capital Corp.

Sachem Capital Corp is a real estate investment trust. The company specializes in originating, underwriting, funding, servicing, and managing a portfolio of short-term loans secured by first mortgage liens on real property located in Connecticut. Its primary objective is to grow the loan portfolio while protecting and preserving capital in a manner that provides for attractive risk-adjusted returns to shareholders over the long term through dividends. The company earns the majority of its revenue through Interest income from loans.

Share on Social Networks: